Notice of the Asia-Pacific Specialty Disease and Specialty Medical Center Construction and Evaluation Seminar

To advance Asia-Pacific specialty disease and specialty medical center development from resource participation toward stable collaboration, function building, quality improvement, and continuous evaluation, the Asia-Pacific Health Association proposes to convene the Asia-Pacific Specialty Disease and Specialty Medical Center Construction and Evaluation Seminar on November 6, 2026, while recruiting professionals across the Asia-Pacific region in construction research, professional evaluation, quality improvement, research and education, data governance, artificial intelligence applications, and cross-regional collaboration.

This notice is intended to invite seminar registrations and expressions of interest from evaluation professionals. The registration method, application materials, and detailed process for evaluation professionals will be announced separately after confirmation.

1. Basic Conference Information

2. Main Topics

· The functional boundaries, development logic, and value of regional collaboration for Asia-Pacific specialty disease and specialty medical centers.

· The four-level development pathway: Asia-Pacific Specialty Disease and Specialty Medical Center Partnership Development Institution; Asia-Pacific Specialty Disease and Specialty Medical Center Partnership Institution; Asia-Pacific Specialty Disease and Specialty Medical Center (Single or Multiple Functions); and Asia-Pacific Specialty Disease and Specialty Medical Center (Full Functions).

· The internal collaboration mechanism from partnership development to center development, including the conditions for establishing training, consultation, multidisciplinary collaboration, research and education, quality improvement, referral coordination, and follow-up management functions.

· The evidence chain, boundaries, annual review, and corrective-action closure for professional evaluation; and how evaluation can support capacity building while taking into account applicable cross-regional administrative approvals and the statutory qualifications of healthcare institutions.

· The categories, basic requirements, competency requirements, conflict-of-interest disclosure and recusal, training, and continuing competency maintenance for evaluation professionals.

· Exchange of pilot experience in specialty disease projects, including practical issues concerning professional collaboration, consultation, and professional participation in areas such as chronic lung disease in infants and young children.

· Ethical and compliance issues related to internationalization, data governance, the assisted use of artificial intelligence, patient safety, and cross-regional collaboration.

3. Intended Participants

Participation is welcome from healthcare institutions; specialty disease and specialty teams; medical, nursing, allied health, pharmacy, rehabilitation, and care professionals; medical education and research professionals; hospital and quality managers; data and artificial intelligence professionals; health policy and legal and compliance professionals; and representatives of Asia-Pacific partner institutions and relevant professional organizations.

Attendance is not conditional on joining the evaluation professional pool, and applying to become an evaluation professional is not conditional on attending this seminar. The two types of applications will be reviewed separately.

4. Evaluation Talent Recruitment

4.1 Recruitment Areas

· Specialty disease and specialty evaluation professionals: specialty disease leads, relevant clinical specialists, multidisciplinary care experts, nursing, rehabilitation, imaging, pathology, genetics, respiratory therapy, and other medical technical professionals.

· Healthcare quality and patient safety professionals: professionals in healthcare quality, patient safety, infection prevention and control, clinical pathways, risk management, and continuous improvement.

· Research, education, and evidence-based practice professionals: professionals in clinical research, translational research, epidemiology, health statistics, health economics, medical education, and professional translation.

· Data, digital health, and artificial intelligence professionals: professionals in medical data governance, information systems, data security, digital health, and artificial intelligence governance.

· International collaboration and project management professionals: professionals in cross-regional collaboration, cross-cultural communication, project management, institutional exchange, referral coordination, and patient services.

· Legal and compliance support professionals: professionals in health law, ethics review, privacy protection, intellectual property, contracts, and cross-border compliance.

4.2 Basic Requirements

· Applicants should have a genuine and verifiable professional identity, educational background, work experience, or project experience, and be able to provide the necessary supporting materials.

· Applicants should support an evaluation approach based on patient safety, professional quality, evidence-based practice, continuous improvement, and cross-regional collaboration.

· Applicants must comply with evaluation discipline, confidentiality requirements, conflict-of-interest disclosure, and recusal rules, and must not use their status as association evaluation professionals to claim administrative approval, medical practice qualifications, or statutory certification qualifications.

· Applicants should be willing to participate in necessary training, case discussions, evaluation-method learning, and annual competency maintenance, and to undertake relevant professional tasks as scheduled.

· Applicants must not have undisclosed material conflicts of interest, false publicity, academic misconduct, or other circumstances that could affect fair evaluation.

4.3 Participation and Proposed Responsibilities

After review, evaluation professionals may participate, according to their areas of expertise, in indicator discussions, evidence review, peer exchange, on-site or remote verification, corrective-action review, training delivery, research collaboration, and improvement of evaluation methods. Specific tasks will be based on written assignments, task orders, or project arrangements. Participation in the recruitment process does not constitute a fixed appointment or guarantee participation in any particular evaluation project.

4.4 Recruitment Process

· Submit basic information, professional area, work experience, and verifiable supporting materials.

· The association or its authorized working group will conduct a formal review, professional matching, and necessary background verification.

· Participate in training or orientation on evaluation methods, ethics and compliance, conflicts of interest, evidence management, and communication rules.

· After completing conflict-of-interest disclosure and a confidentiality undertaking, participate in pilot or observational tasks as required by the project.

· Based on participation records, professional performance, and annual review results, applicants may be placed on an evaluation professional roster, candidate roster, or development roster.

5. Evaluation and Compliance Boundaries

This seminar and the recruitment of evaluation professionals are organized by the Asia-Pacific Health Association as professional research, exchange, and capacity-evaluation activities of the association. The relevant level names and evaluation results are intended only for professional collaboration, capacity building, peer exchange, quality improvement, and project management. They do not constitute administrative approval, healthcare institution practice qualifications, statutory certification, a guarantee of clinical efficacy, authorization for cross-regional practice, or certification by any certification body in mainland China or elsewhere.

The partnership is a cross-regional professional collaboration platform organized by the association and is not equivalent to a statutory medical alliance established by a health administrative authority in mainland China. Training, exchange, research, and education shall be undertaken lawfully by the relevant parties. Responsibility for consultation, diagnosis and treatment, patient referral, and patient safety shall be borne by legally practicing healthcare institutions and professionals.

The evaluation process does not impose a specified brand, specified product, China-manufactured content ratio, or purchase of services as a general condition for passing. Activities involving healthcare services, data, patient information, or artificial intelligence applications shall comply with applicable laws and regulations, ethical requirements, privacy protections, and institutional policies.

6. Registration and Submission of Materials

Materials submitted by applicants shall be limited to those necessary for seminar organization, professional matching, evaluation competency review, and project collaboration. Personal information, institutional materials, case materials, and research materials shall be authorized, de-identified, kept confidential, and securely managed in accordance with applicable requirements.

7. Organizing Parties and Follow-up Arrangements

The registration portal, evaluation professional application materials, subsequent agenda, and on-site arrangements will be announced after the responsible parties and release conditions have been confirmed.

Institutions and professionals are welcome to provide comments on specialty disease and specialty medical center development, professional evaluation, and workforce development, and to submit their participation interest through the formal registration channel.